ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) Stock Price & Overview

BIT:1ROG • CH0012032048

370 EUR
-4 (-1.07%)
Last: Mar 10, 2026, 07:00 PM

The current stock price of 1ROG.MI is 370 EUR. Today 1ROG.MI is down by -1.07%. In the past month the price increased by 8.19%.

1ROG.MI Key Statistics

1-Month Range336 - 402
Current 1ROG.MI stock price positioned within its 1-month range.
Market Cap
299.423B
P/E
17.16
Fwd P/E
16.00
EPS (TTM)
21.56
Dividend Yield
2.70%

1ROG.MI Stock Performance

Today
-1.07%
1 Week
-9.31%
1 Month
+8.19%
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

1ROG.MI Stock Chart

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG Daily stock chart

1ROG.MI Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to 1ROG.MI.


Chartmill TA Rating
Chartmill Setup Rating
1ROG.MI Full Technical Analysis Report

1ROG.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1ROG.MI. 1ROG.MI has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1ROG.MI Full Fundamental Analysis Report

1ROG.MI Earnings

On January 29, 2026 1ROG.MI reported an EPS of 8.36 and a revenue of 30.57B. The company missed EPS expectations (-5.46% surprise) and missed revenue expectations (-3.25% surprise).

Next Earnings DateApr 23, 2026
Last Earnings DateJan 29, 2026
PeriodQ4 / 2025
EPS ReportedCHF8.36
Revenue Reported30.572B
EPS Surprise -5.46%
Revenue Surprise -3.25%
1ROG.MI Earnings History

1ROG.MI Forecast & Estimates

For the next year, analysts expect an EPS growth of 7.31% and a revenue growth 2.76% for 1ROG.MI


Analysts
Analysts71.72
Price TargetN/A
EPS Next Y7.31%
Revenue Next Year2.76%
1ROG.MI Forecast & Estimates

1ROG.MI Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

1ROG.MI Financial Highlights

Over the last trailing twelve months 1ROG.MI reported a non-GAAP Earnings per Share(EPS) of 21.56. The EPS increased by 3.51% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)9.43B
Industry RankSector Rank
PM (TTM) 15.31%
ROA 9.95%
ROE 32.88%
Debt/Equity 1.06
Chartmill High Growth Momentum
EPS Q2Q%-2.45%
Sales Q2Q%-0.24%
EPS 1Y (TTM)3.51%
Revenue 1Y (TTM)N/A
1ROG.MI financials

1ROG.MI Ownership

Ownership
Inst Owners40.79%
Shares809.25M
Float689.62M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
1ROG.MI Ownership

1ROG.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SNW SANOFI9.01184.842B
SAN SANOFI9.01184.817B
1SAN SANOFI9.01184.6B
UNC UCB SA24.2749.211B
UCB UCB SA24.2749.133B
1MRK MERCK KGAA12.948.217B
MRK MERCK KGAA13.0447.587B
BAYN BAYER AG-REG8.2538.442B
1BAYN BAYER AG-REG8.3638.422B
IPN IPSEN12.4812.848B
REC RECORDATI INDUSTRIA CHIMICA15.879.733B
TUB FINANCIERE DE TUBIZE N/A9.681B
VIRP VIRBAC SA15.372.806B

About 1ROG.MI

Company Profile

1ROG logo image Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 103,249 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Company Info

IPO: 2001-05-04

ROCHE HOLDING AG-GENUSSCHEIN

Grenzacherstrasse 124

Basel BASEL-STADT CH

Employees: 103249

1ROG Company Website

1ROG Investor Relations

Phone: 41616881111

ROCHE HOLDING AG-GENUSSCHEIN / 1ROG.MI FAQ

Can you describe the business of ROCHE HOLDING AG-GENUSSCHEIN?

Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 103,249 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.


What is the current price of 1ROG stock?

The current stock price of 1ROG.MI is 370 EUR. The price decreased by -1.07% in the last trading session.


What is the dividend status of ROCHE HOLDING AG-GENUSSCHEIN?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a dividend yield of 2.7%. The yearly dividend amount is currently 11.07.


What is the ChartMill rating of ROCHE HOLDING AG-GENUSSCHEIN stock?

1ROG.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the Price/Earnings (PE) ratio of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI)?

The PE ratio for ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) is 17.16. This is based on the reported non-GAAP earnings per share of 21.56 and the current share price of 370 EUR.


What is the market capitalization of 1ROG stock?

ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) has a market capitalization of 299.42B EUR. This makes 1ROG.MI a Mega Cap stock.


What is the ownership structure of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI)?

You can find the ownership structure of ROCHE HOLDING AG-GENUSSCHEIN (1ROG.MI) on the Ownership tab.